RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,807,000 | -0.8% | 662,056 | +20.4% | 0.02% | 0.0% |
Q1 2017 | $1,821,000 | +97.3% | 550,000 | +41.9% | 0.02% | +100.0% |
Q4 2016 | $923,000 | -68.8% | 387,697 | -51.8% | 0.01% | -62.5% |
Q3 2016 | $2,954,000 | +32.5% | 805,000 | -19.5% | 0.03% | +39.1% |
Q2 2016 | $2,229,000 | +7.2% | 999,700 | 0.0% | 0.02% | +53.3% |
Q1 2016 | $2,079,000 | +29.8% | 999,700 | +89.1% | 0.02% | +50.0% |
Q4 2015 | $1,602,000 | – | 528,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
UBS OCONNOR LLC | 1,151,765 | $1,243,906 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |